EC
RVMD icon

EcoR1 Capital’s Revolution Medicines RVMD Stock Holding History

EcoR1 Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-132,579
Closed -$3.8M – 64
2023
Q4 		$3.8M Sell
132,579
-5,445,284
-98% -$131M 0.1% 40
2023
Q3 		$154M Sell
5,577,863
-1,620,837
-23% -$48.1M 5.21% 5
2023
Q2 		$193M Buy
7,198,700
+1,846,517
+35% +$45.3M 4.72% 7
2023
Q1 		$116M Buy
5,352,183
+893,452
+20% +$22M 3.73% 8
2022
Q4 		$106M Buy
4,458,731
+2,656,884
+147% +$56.5M 3.23% 8
2022
Q3 		$35.5M Sell
1,801,847
-2,476,222
-58% -$54.4M 1.05% 21
2022
Q2 		$83.4M Buy
4,278,069
+3,003,972
+236% +$58.5M 2.88% 13
2022
Q1 		$32.5M Buy
+1,274,097
New +$27.7M 1.02% 24

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

EcoR1 Capital's RVMD Position: Q1 2024 in Review

EcoR1 Capital sold out of Revolution Medicines (RVMD) in Q1 2024, closing a stake of 132,579 shares — an estimated $3.8M sold.

EcoR1 Capital first reported a position in RVMD in Q1 2022 and held it in 8 quarters. The position peaked at $193M in Q2 2023. 210 funds tracked by Wall St. Rank hold RVMD as of Q1 2024.

  • EcoR1 Capital reported no remaining Revolution Medicines position as of Q1 2024 after selling out during the quarter.
  • EcoR1 Capital sold 132,579 Revolution Medicines shares in Q1 2024, an estimated $3.8M.
  • EcoR1 Capital first reported a position in Revolution Medicines in Q1 2022 and held it in 8 quarters.
  • EcoR1 Capital's Revolution Medicines position peaked at $193M in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2024.

Based on EcoR1 Capital's 13F filing for Q1 2024, filed 15 May 2024.